CAPITAL INTERNATIONAL SARL
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1065349
Los Angeles, CA
Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$17,483,822
-$167,761 QoQ
Shares Held
58,080
+8.9% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#141
of 786 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $261,404,130 across 8 Biotechnology names. ALNY ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,718 | $104,669,952 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,076,063 | $60,334,852 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
175,542 | $50,024,203 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
58,080 | $17,483,822 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,458 | $15,874,081 | |
| 6 | ASND |
Ascendis Pharma A/S
|
26,222 | $6,993,931 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
101,238 | $5,521,520 | |
| 8 | CYTK |
Cytokinetics Inc
|
5,890 | $501,769 |
All Filings in ALNY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,483,822 | 58,080 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $17,651,583 | 53,349 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $47,460,322 | 119,352 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $59,144,112 | 129,702 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $41,832,781 | 128,286 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $32,715,623 | 121,160 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,094,064 | 115,142 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $37,149,127 | 135,073 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $26,685,045 | 109,815 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,926,140 | 73,109 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $16,721,003 | 87,357 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,393,886 | 86,922 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,030,746 | 84,399 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,442,668 | 77,090 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,893,081 | 66,876 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,872,092 | 44,325 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,502,243 | 30,869 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,174,206 | 13,315 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||